Hazelden Betty Ford Foundation v. My Way Betty Ford Klinik GmbH

CourtDistrict Court, D. Minnesota
DecidedAugust 20, 2021
Docket0:20-cv-00409
StatusUnknown

This text of Hazelden Betty Ford Foundation v. My Way Betty Ford Klinik GmbH (Hazelden Betty Ford Foundation v. My Way Betty Ford Klinik GmbH) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hazelden Betty Ford Foundation v. My Way Betty Ford Klinik GmbH, (mnd 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

HAZELDEN BETTY FORD FOUNDATION and ELIZABETH B. FORD CHARITABLE Civil No. 20-409 (JRT/TNL) TRUST,

Plaintiffs, MEMORANDUM

OPINION AND ORDER v.

MY WAY BETTY FORD KLINIK, GmbH

Defendant.

Laura L. Myers and Nirmani Chethana Perera, FREDRIKSON & BYRON PA, 200 South Sixth Street, Suite 4000, Minneapolis, MN 55402, for plaintiffs.

Alan M. Anderson and L. Reagan Florence, ALAN ANDERSON LAW FIRM LLC, 11100 Wayzata Boulevard, Suite 545 Minneapolis, MN 55305, for defendant.

Plaintiffs Hazelden Betty Ford Foundation (“Hazelden”) and the Elizabeth B. Ford Charitable Trust (the “Betty Ford Trust”) brought an action against Defendant My Way Betty Ford Klinik GmbH (“MWBF Klinik”) for statutory and common law trademark infringement, unfair competition, false advertising, cybersquatting, and infringement of the right to publicity under California law. On December 1, 2020, the Court issued an order denying MWBF Klinik’s motion to dismiss for lack of personal jurisdiction. MWBF Klinik then filed a Motion for Certification for Interlocutory Appeal pursuant to 28 U.S.C. § 1292(b). Because MWBF Klinik has not demonstrated that the order raises a controlling question of law warranting immediate appeal, the Court will deny the Motion for Certification.

MWBF Klinik also filed a Motion for Judgment on the Pleadings pursuant to Federal Rules of Civil Procedure 12(c), or in the alternative, for Summary Judgment. Because the Court finds that Plaintiffs plausibly plead claims for which relief may be granted, the Court will deny MWBF Klinik’s Motion for Judgment on the Pleadings. Additionally, because

discovery has not yet commenced and Plaintiffs have not yet had the opportunity to develop the factual record to support their claims, the Court finds that summary judgment would be premature at this time and will deny MWBF Klinik’s alternative

Motion for Summary Judgment. BACKGROUND

I. FACTUAL BACKGROUND The facts of this matter were documented in detail in the Court’s prior order. See

Hazelden Betty Ford Found. v. My Way Betty Ford Klinik GmbH, 504 F. Supp. 3d 966, 970– 73 (D. Minn. 2020). As relevant here, Plaintiffs operate drug and alcohol treatment programs across the United States and hold exclusive rights to the use and licensing of the Betty Ford Marks, which are associated with Plaintiffs’ distinct treatment model.

(Am. Compl. ¶¶ 1–2, 10–16, 18, Feb. 5, 2020, Docket No. 6.) MWBF Klinik is a German entity that operates a drug and alcohol treatment facility in Bad Brückenau, Germany. (Id. ¶ 5.) In 2012, MWBF Klinik contacted the Betty Ford Center (“BFC”) to propose a cooperative business relationship. (Id. ¶ 21.)

Over the course of the next two years, MWBF Klinik representatives visited BFC in California and engaged in email and phone communications with Plaintiffs regarding MWBF Klinik’s interest in forming a business relationship. (Id. ¶¶ 22–34.) MWBF Klinik claimed that a cooperative business arrangement would provide legal cover for MWBF

Klinik’s continued use of the Betty Ford marks in Germany and would advance Plaintiffs’ intellectual property and business interests in Europe and the Middle East. (Id. ¶¶ 24, 29, 31; Myers Decl. ¶ 4, Ex. C at 16, Aug. 24, 2020, Docket No. 25-1.) Throughout these

discussions, MWBF Klinik represented that it would adopt another name and cease its use of “Betty Ford” if the parties could not come to an agreement. (Am. Compl. ¶ 31.) In April of 2014, MWBF Klinik representatives traveled to Minnesota to meet with Hazelden; Hazelden informed MWBF Klinik in writing at that meeting that it would not

provide a license to use the Betty Ford name and that it relied on MWBF Klinik’s prior assurances that it would change its name and cease using references to “Betty Ford” by July 1, 2015. (Id. ¶¶ 35–37.) MWBF Klinik has continued to use the “Betty Ford” name, including on its website.

(Id. ¶¶ 38–39.) As a result, Plaintiffs allege that MWBF Klinik has misrepresented its affiliation with Plaintiffs in promoting its services. (Id. ¶¶ 40–44.) Plaintiffs also aver that they have received communications at their offices in the United States from prospective patients, MWBF Klinik patients, and the contacts of MWBF Klinik patients expressing confusion about the relationship between the entities, and have documented other

instances of actual confusion among consumers in the United States and abroad. (Id. ¶¶ 45–48; see also 2nd Decl. Laura L. Meyers ¶¶ 4–6, 9–13, Feb. 2, 2021, Docket No. 64.)

II. PROCEDURAL BACKGROUND On January 30, 2020, Plaintiffs filed suit against Defendant MWBF Klinik in the District of Minnesota. (Compl., Jan. 30, 2020, Docket No 1.) Plaintiffs filed an Amended

Complaint on February 5, 2020, alleging six counts for trademark infringement under 15 U.S.C. § 1114, unfair competition under 15 U.S.C. § 1125(a), false advertising under 15 U.S.C. § 1125(b), common law trademark infringement, cybersquatting in violation of 15 U.S.C. § 1125(d), and right of publicity infringement pursuant to California Civil Code

§ 3344.1. (Am. Compl. ¶¶ 52-134.) On August 3, 2020, MWBF Klinik filed a motion to dismiss for lack of personal jurisdiction under Federal Rule of Civil Procedure 12(b)(2). (Mot. Dismiss, Aug. 3, 2020, Docket No. 15.) The Court denied the motion, finding that personal jurisdiction existed

pursuant to Rule 4(k)(2). Hazelden, 504 F. Supp. 3d at 978. MWBF Klinik then filed a Motion to Certify Interlocutory Appeal. (Mot. Certify Interlocutory Appeal Dec. 28, 2020, Docket No 42.) MWBF Klinik subsequently filed a Motion for Judgment on the Pleadings, or, in the alternative, for Summary Judgment. (Mot. J. Pleadings, Jan. 12, 2021, Docket No. 57.)

Plaintiffs oppose both Motions. DISCUSSION

I. MOTION TO CERTIFY INTERLOCUTORY APPEAL MWBF Klinik asks the Court to certify two questions for interlocutory appeal: which

party bears the burden of proving the non-existence of jurisdiction in any other forum in the United States under Federal Rule of Civil Procedure 4(k)(2); and whether personal jurisdiction over MWBF Klinik as a foreign defendant is proper under Rule 4(k)(2). MWBF

Klinik argues that the court’s application of Rule 4(k)(2) is a question of law that has not been settled by the Eighth Circuit and asks the court to stay proceedings pending an interlocutory appeal.

A. Standard of Review Section 1292(b) creates a narrow exception to the final judgment rule and allows district courts to certify orders for interlocutory appeal if certain criteria are satisfied and

the district court determines that certification is appropriate. 28 U.S.C. § 1292(b); see also White v. Nix, 43 F.3d 374, 377 (8th Cir. 1994).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Steele v. Bulova Watch Co.
344 U.S. 280 (Supreme Court, 1952)
Arbaugh v. Y & H Corp.
546 U.S. 500 (Supreme Court, 2006)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Ray v. American Airlines, Inc.
609 F.3d 917 (Eighth Circuit, 2010)
McBee v. Delica Co., Ltd.
417 F.3d 107 (First Circuit, 2005)
Clemons v. Crawford
585 F.3d 1119 (Eighth Circuit, 2009)
Ashley County, Ark. v. Pfizer, Inc.
552 F.3d 659 (Eighth Circuit, 2009)
Braden v. Wal-Mart Stores, Inc.
588 F.3d 585 (Eighth Circuit, 2009)
Union County, Iowa v. Piper Jaffray & Co., Inc.
525 F.3d 643 (Eighth Circuit, 2008)
Gucci America, Inc. v. Guess?, Inc.
790 F. Supp. 2d 136 (S.D. New York, 2011)
La Quinta Worldwide LLC v. Q.R.T.M., S.A. De C.V.
762 F.3d 867 (Ninth Circuit, 2014)
Axiom Foods, Inc. v. Acerchem International, Inc.
874 F.3d 1064 (Ninth Circuit, 2017)
Sterling Drug, Inc. v. Bayer AG
14 F.3d 733 (Second Circuit, 1994)
Coca-Cola Co. v. Stewart
621 F.2d 287 (Eighth Circuit, 1980)

Cite This Page — Counsel Stack

Bluebook (online)
Hazelden Betty Ford Foundation v. My Way Betty Ford Klinik GmbH, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hazelden-betty-ford-foundation-v-my-way-betty-ford-klinik-gmbh-mnd-2021.